
Formats: [HTML](/news/2018/01/8/pharmaceutical-company-pfizer-discontinues-research-into-treating-patients-with-alzheimer-s-disease-and-parkinson-s-disease-http-www-tel.html)  [JSON](/news/2018/01/8/pharmaceutical-company-pfizer-discontinues-research-into-treating-patients-with-alzheimer-s-disease-and-parkinson-s-disease-http-www-tel.json)  [XML](/news/2018/01/8/pharmaceutical-company-pfizer-discontinues-research-into-treating-patients-with-alzheimer-s-disease-and-parkinson-s-disease-http-www-tel.xml)  

### [2018-01-8](/news/2018/01/8/index.md)

# Pharmaceutical company Pfizer discontinues research into treating patients with Alzheimer's disease and Parkinson's disease. [http:--www.telegraph.co.uk-science-2018-01-08-hunt-alzheimers-cure-suffers-heavy-blow-pfizer-pulls-research- "(The Telegraph)" ]




### Changes:

1. [Pfizer discontinues research into treating Alzheimer's disease and Parkinson's disease. [http:--www.telegraph.co.uk-science-2018-01-08-hunt-alzheimers-cure-suffers-heavy-blow-pfizer-pulls-research- "(The Telegraph)"]](/news/2018/01/8/pfizer-discontinues-research-into-treating-alzheimeras-disease-and-parkinson-s-disease-http-www-telegraph-co-uk-science-2018-01-08-hun.md) _2018-01-08 22:30:06 (First version)_
1. [Pharmaceutical company Pfizer discontinues research into treating patients with Alzheimer's disease and Parkinson's disease. [http:--www.telegraph.co.uk-science-2018-01-08-hunt-alzheimers-cure-suffers-heavy-blow-pfizer-pulls-research- "(The Telegraph)" ]](/news/2018/01/8/pharmaceutical-company-pfizer-discontinues-research-into-treating-patients-with-alzheimer-s-disease-and-parkinson-s-disease-http-www-tel.md) _(Current version)_

### Related:

1. [Because of a nationwide shortage of intravenous sodium bicarbonate (i.e., baking soda solution), United States hospitals are rationing its use in heart surgery, chemotherapy, for patients whose blood is too acidic, and as an antidote to certain poisons. The two primary producers, Amphastar and Pfizer, indicate that supplies will not increase until late June. ](/news/2017/05/22/because-of-a-nationwide-shortage-of-intravenous-sodium-bicarbonate-i-e-baking-soda-solution-united-states-hospitals-are-rationing-its-u.md) _Context: Pfizer_
2. [Pfizer Inc. decides to terminate its $160 billion merger with Allergan, Plc as officials in Washington crack down on corporate inversions. Pfizer will need to pay a $400 million fee to Allergan for expenses relating to the deal. ](/news/2016/04/5/pfizer-inc-decides-to-terminate-its-160-billion-merger-with-allergan-plc-as-officials-in-washington-crack-down-on-corporate-inversions-p.md) _Context: Pfizer_
3. [The U.S. Treasury Department announces new regulations to curb tax-avoiding corporate inversions, i.e., where U.S. companies slash their tax bills by claiming a new tax home overseas, though their core operations and management remain in the United States. The pending $160 billion merger of Pfizer Inc. and Allergan, Plc could be cancelled because of these new rules. ](/news/2016/04/4/the-u-s-treasury-department-announces-new-regulations-to-curb-tax-avoiding-corporate-inversions-i-e-where-u-s-companies-slash-their-tax.md) _Context: Pfizer_
4. [American pharmaceutical companies Pfizer and Allergan, Plc announce plans to merge to form the world's largest drug company. The merger is subject to approval from regulators in the U.S., European Union and elsewhere as well as approval by shareholders of both companies. If approved, the deal will reduce tax revenue paid to the U.S. by approximately $930 million. ](/news/2015/11/23/american-pharmaceutical-companies-pfizer-and-allergan-plc-announce-plans-to-merge-to-form-the-world-s-largest-drug-company-the-merger-is-s.md) _Context: Pfizer_
5. [The Obama Administration through the U.S. Treasury Department will clamp down further on corporate income tax-avoiding inversion deals by U.S. companies with foreign rivals. There is a pending inversion deal between U.S. drug maker Pfizer Inc. and smaller Irish competitor Allergan, Plc. ](/news/2015/11/18/the-obama-administration-through-the-u-s-treasury-department-will-clamp-down-further-on-corporate-income-tax-avoiding-inversion-deals-by-u.md) _Context: Pfizer_
